Emyria’s Rapid Clinic Expansion Drives 208% Revenue Surge, Fueling Psychedelic Medicine Growth
EMyria Ltd surges 208% revenue, expands clinics into NSW and Sydney, and secures FDA spotlight—positioning it as a top player in Australia’s psychedelic‑medicine boom.
2 minutes to read




